最高の Hemet ポッドキャスト (2024)

1
Blood Transfusion Safety: TRALI vs TACO 20:03

14d ago20:03

20:03

Join us as we explore blood transfusion safety, focusing specifically on Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO). Tailored for general hematologists with a foundational understanding of transfusion medicine, this session delves into the pathophysiology, clinical presentation, diagnostic c…

1
Advancing Sickle Cell Disease Care: Navigating Gene Therapy 17:11

2M ago17:11

17:11

Are you a hematologist or a generalist provider seeking clarity on how to best counsel patients with sickle cell disease (SCD) who are interested in gene therapy? Join us for a podcast session focused on important patient considerations for gene therapy, tailored for SCD providers and clinicians. This session aims to provide practical insights to f…

1
Updates in Thalassemia: New Challenges and Novel Treatment Approaches 20:19

3M ago20:19

20:19

Speakers: Alexis Thompson, MD, and Sujit Sheth, MD Description: For general hematologists with a foundational understanding of thalassemia, this episode discusses the changing demographics due to immigration and refugee resettlement. It covers the diagnosis process from newborn screening to older individuals, emphasizing genetic testing due to nume…

1
Multiple Myeloma in Underrepresented Populations: Treatment Considerations 24:04

9M ago24:04

24:04

Dr. Azam Farooqui (@azamfarooqui ) and Dr. Monique Hartley-Brown (@DrMHB1) discuss therapeutic considerations regarding current and emerging agents for patients with multiple myeloma from underrepresented racial and ethnic groups. Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! P…

1
Multiple Myeloma in Underrepresented Populations: Survival Outcomes 18:54

9M ago18:54

18:54

Dr. Azam Farooqui (@azamfarooqui )and Dr. Sikander Ailawadhi answer the question: Why do we need earlier diagnosis and intervention in patients with multiple myeloma from underrepresented racial and ethnic groups? Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! Participants will …

1
Multiple Myeloma in Underrepresented Populations: Clinical Risk 16:42

9M ago16:42

16:42

Dr. Azam Farooqui (@azamfarooqui) and Dr. Urvi Shah (@UrviShahMD) identify factors that impact outcomes for patients with multiple myeloma from underrepresented racial and ethnic groups. Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! Participants will develop an increased abilit…

1
IMPACT II: Impacting Multiple Myeloma in All CommuniTies 1:33

9M ago1:33

1:33

Season 2: IMPACT II: Impacting Multiple Myeloma in All CommuniTies Unlock insights into the treatment of multiple myeloma within underrepresented racial and ethnic populations with this series of three enlightening podcast episodes. Join experts from both academic and community oncology settings as they dive into critical aspects of clinical risk, …

1
GENOM: Myelodysplastic Syndromes and Clonal Hematopoiesis 16:31

1+ y ago16:31

16:31

Dr. Michael Diaz (@mdiazoncmd) and Dr. Namrata Chandhok (@NamrataChandhok) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myelodysplastic syndromes and clonal hematopoiesis. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malig…

1
GENOM: Acute Myeloid Leukemia 17:44

1+ y ago17:44

17:44

Dr. Michael Diaz (@mdiazoncmd) and Dr. James Blachly (@jamesblachly) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute myeloid leukemia. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collabo…

1
GENOM: Acute Lymphoblastic Leukemia 22:07

1+ y ago22:07

22:07

Dr. Michael Diaz (@mdiazoncmd) and Dr. Emily K. Curran (@ECurranMD) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute lymphoblastic leukemia. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a co…

1
GENOM: Myeloma 20:12

1+ y ago20:12

20:12

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. Ajai Chari (@AjaiChari) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myeloma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between th…

1
GENOM: Lymphoma 16:02

1+ y ago16:02

16:02

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. David Russler-Germain (@dgermain21) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with lymphoma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaborati…

1
GENOM: Chronic Lymphocytic Leukemia 16:37

1+ y ago16:37

16:37

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. Jacqueline Barrientos discuss the importance of genomic testing and how to understand and interpret test results when treating patients with chronic lymphocytic leukemia (CLL). They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a…

1
HemeTalks, a podcast featuring conversations in hematology education. 1:24

1+ y ago1:24

1:24

HemeTalks: Conversations in Hematology Education is a brand-new podcast from the American Society of Hematology (ASH)! Listen to educational content from ASH developed by subject-matter experts to meet your professional education needs. Whether you’re a clinician or researcher, ASH has innovative education for every career stage and subspecialty. S…